Tel Aviv Sourasky Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2023

  1. Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes

    Leukemia Research, Vol. 134